bpc-157 reduces oxidative stress Peptide Therapy for Inflammation: A New Solution Sample of patents with BPC
Description
Research has shown it can modulate glutamate activity, the brains primary excitatory neurotransmitter that opposes GABA
Funding TV is a senior clinical investigator of the Flanders Research Foundation (FWO Vlaanderen) and JT was supported by a Methusalem grant of the KU Leuven
to 500 mcg
It has also been shown to lower homocysteine levels, a molecule linked to inflammation and cognitive decline, with longitudinal studies linking optimal B12 levels with improved cognitive function, mood and reduced risk of neurodegenerative disease
Peptide therapy has rapidly become one of the most exciting breakthroughs in longevity, cellular health, and functional medicine
